WeTrials
Recruiting

Chronic Convection Enhanced Delivery of Topotecan for Recurrent Malignant Glioma

What is this study?

This study tests a new way to deliver chemotherapy directly to a returning brain tumor using a small pump system. Researchers want to see if this direct delivery method is safe and how well it reaches the tumor.

Who can participate?

You might be eligible if you have a specific type of fast-growing brain tumor that has returned after standard treatments and meets certain size and location requirements. Participants also need to be well enough to perform normal daily activities and pass health screenings.

What will happen?

A small pump will be placed under your skin and connected to a tiny tube that delivers medicine directly to the brain tumor over several weeks. Your health will be carefully monitored with regular exams, blood tests, and brain scans before the pump is eventually removed and the tumor is surgically treated.

Where and when?

This study is currently recruiting participants and takes place in New York, New York.

Key Points
  • 1Tests a direct drug delivery method for returning brain tumors
  • 2Involves a specialized pump system and regular health monitoring
  • 3Currently recruiting patients in New York

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Brain Tumor, RecurrentMalignant Glioma (WHO Grade III or IV)IDH1/IDH2 Mutation

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.